A Revolutionary 21st Century Platform for Research, Development, and Testing of Pharmaceuticals, Nutraceuticals and Cosmeceuticals, Avoiding the Need for Animal Testing. is a US-based corporation, which has created a technology platform for in silico drug discovery and development through quantitative modeling of complex molecular pathways - potentially supplanting the need for animal testing and reducing the time it takes for drugs or nutraceuticals to be brought to market. CytoSolve specializes in the use of its technology platform for discovery of multi-combination compounds for both the prevention and
cure of major diseases such as cancer, obesity, inflammation and others. CytoSolve’s core technology platform, provides a method for drug development as well as for developing combinatorial drug therapies, has been the basis of scientific study and interest in a number of university research projects.
